Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer

• Status: Unknown status
• Trial end date: 2020-09-30
• Target enrollment: 0
• Participant gender: All

Summary

This study is being done to find the effect of Dibenzyl Trisulphide (active ingredient in Guinea Hen Weed in combination in patients with stage four cancer of the breast, prostate, cervix and colon.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of The West Indies

Criteria

Inclusion Criteria:

• Age: Greater than 12 years.

• Documented histologic evidence of cancer

• Staged as stage IV

• World Health Organization (WHO) Performance Status of between 0 and 2

• Radiological confirmation of metastases with bone scan or X ray, CT and/or MRI scan Exclusion Criteria

• Cancer stages less than stage 4

• Pregnant women

• Children 0 - 12 years